Cresco Labs (CRLBF) Non Operating Investment Income (2020 - 2025)
Cresco Labs (CRLBF) reported Non Operating Investment Income of -$3000.0 for Q3 2025, down 121.43% on a YoY basis from $14000.0 in Q3 2024, and down 123.08% quarter-over-quarter from $13000.0 in Q1 2025.
Cresco Labs (CRLBF) Non Operating Investment Income (2020 - 2025) Analysis & Trends
Cresco Labs has reported Non Operating Investment Income for 6 years, with the latest figure at -$3000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | Cresco Labs | - | - | 75.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3,000.00 |
| Sep 30, 2025 | -3,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Mar 31, 2025 | 13,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Mar 31, 2024 | 63,000.00 |
| Sep 30, 2023 | 123,000.00 |
| Sep 30, 2023 | 123,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Jun 30, 2023 | 262,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Mar 31, 2023 | 37,000.00 |
| Sep 30, 2022 | 268,000.00 |
| Sep 30, 2022 | 268,000.00 |
| Jun 30, 2022 | 2.20 Mn |
| Jun 30, 2022 | 2.20 Mn |